Literature DB >> 17721373

Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode.

María E Santolaya1, Ana M Alvarez, Carmen L Avilés, Ana Becker, Claudio Mosso, Miguel O'Ryan, Ernesto Payá, Carmen Salgado, Pamela Silva, Santiago Topelberg, Juan Tordecilla, Mónica Varas, Milena Villarroel, Tamara Viviani, Marcela Zubieta.   

Abstract

BACKGROUND: Early identification of children with cancer at risk for death during a febrile neutropenic (FN) episode may increase their possibility for survival. Our aim was to identify at the time of admission, clinical and laboratory variables differing significantly among children who survived or died during a FN episode.
METHODS: In a prospective, multicenter study, children admitted with a high-risk FN episode were uniformly evaluated at enrollment and managed according to a national consensus protocol. Medical charts of children who died were evaluated to determine whether the death could be associated with an infection. Admission clinical and laboratory variables significantly associated with death were identified.
RESULTS: A total of 393 (70%) of 561 FN episodes evaluated from June 2004 to December 2005 were classified as high risk for invasive bacterial infection, of which 14 (3.6%) resulted in an infectious-related death. Deaths occurred from 2 to 27 days after admission, and most dying children were admitted with relapse of acute lymphocytic leukemia (36%), hypotension (71%), and a diagnosis of sepsis (79%), compared with surviving children (16%, 20%, and 5% respectively, P < 0.001). Children who died were admitted with lower absolute neutrophil count (P < 0.001) and absolute monocytes count levels (P = 0.008), higher blood urinary nitrogen (P = 0.03) and C-reactive protein values (P < 0.001), and had more positive cultures (79% versus 32%, P = 0.008).
CONCLUSIONS: We identified early clinical and laboratory findings significantly associated with death occurring at a later stage. Routine evaluation of these variables may prove to be useful in the early identification of children with a high-risk FN episode at risk for death.

Entities:  

Mesh:

Year:  2007        PMID: 17721373     DOI: 10.1097/INF.0b013e318124aa44

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

1.  Role of urine studies in asymptomatic febrile neutropenic patients presenting to the emergency department.

Authors:  Hady Zgheib; Aline El Zakhem; Cynthia Wakil; Mohamad Ali Cheaito; Rola Cheaito; Antoine Finianos; Ralphe Bou Chebl; Rima Kaddoura; Nader Al Souky; Imad El Majzoub
Journal:  World J Emerg Med       Date:  2021

2.  Protocol for Reducing Time to Antibiotics in Pediatric Patients Presenting to an Emergency Department With Fever and Neutropenia: Efficacy and Barriers.

Authors:  Clay Cohen; Amber King; Chee Paul Lin; Gregory K Friedman; Kathy Monroe; Matthew Kutny
Journal:  Pediatr Emerg Care       Date:  2016-11       Impact factor: 1.454

3.  Can complications in febrile neutropenia be predicted? Report from a developing country.

Authors:  Sapna Oberoi; Anirban Das; Amita Trehan; Pallab Ray; Deepak Bansal
Journal:  Support Care Cancer       Date:  2017-06-11       Impact factor: 3.603

4.  Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia.

Authors:  G Stocco; M H Cheok; K R Crews; T Dervieux; D French; D Pei; W Yang; C Cheng; C-H Pui; M V Relling; W E Evans
Journal:  Clin Pharmacol Ther       Date:  2008-08-06       Impact factor: 6.875

5.  Etiology and clinical course of febrile neutropenia in children with cancer.

Authors:  Hana Hakim; Patricia M Flynn; Katherine M Knapp; Deo Kumar Srivastava; Aditya H Gaur
Journal:  J Pediatr Hematol Oncol       Date:  2009-09       Impact factor: 1.289

6.  Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia.

Authors:  Hana Hakim; Ronald Dallas; Yinmei Zhou; Dequing Pei; Cheng Cheng; Patricia M Flynn; Ching-Hon Pui; Sima Jeha
Journal:  Cancer       Date:  2015-12-23       Impact factor: 6.860

7.  A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.

Authors:  Muayad Alali; Anoop Mayampurath; Yangyang Dai; Allison H Bartlett
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

Review 8.  Staphylococcus aureus - antimicrobial resistance and the immunocompromised child.

Authors:  J Chase McNeil
Journal:  Infect Drug Resist       Date:  2014-05-07       Impact factor: 4.003

9.  The High Prevalence of Functional Complement Defects Induced by Chemotherapy.

Authors:  Mischa P Keizer; Angela M Kamp; Cathelijn Aarts; Judy Geisler; Huib N Caron; Marianne D van de Wetering; Diana Wouters; Taco W Kuijpers
Journal:  Front Immunol       Date:  2016-10-17       Impact factor: 7.561

10.  The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia.

Authors:  Thanyathorn Jungrungrueng; Suvaporn Anugulruengkitt; Supanun Lauhasurayotin; Kanhatai Chiengthong; Hansamon Poparn; Darintr Sosothikul; Piti Techavichit
Journal:  J Pathog       Date:  2021-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.